These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23362935)

  • 1. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.
    Charlot M; Ahlehoff O; Norgaard ML; Jørgensen CH; Sørensen R; Abildstrøm SZ; Hansen PR; Madsen JK; Køber L; Torp-Pedersen C; Gislason G
    Ann Intern Med; 2010 Sep; 153(6):378-86. PubMed ID: 20855802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
    Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
    Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
    Tran M; Tafreshi J; Pai RG
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
    Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
    Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
    Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
    J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
    Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
    Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
    Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
    Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.
    Lin CF; Shen LJ; Wu FL; Bai CH; Gau CS
    Br J Clin Pharmacol; 2012 Nov; 74(5):824-34. PubMed ID: 22364155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
    Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel.
    Chen M; Wei JF; Xu YN; Liu XJ; Huang DJ
    Cardiovasc Ther; 2012 Oct; 30(5):e227-33. PubMed ID: 21884023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
    Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.